European Patients' Rights to Be Protected Against Counterfeit Medicines

Cristina Luiza Erimia, Rodica Sîrbu, Radu George Cazacincu, Emin Cadar, Aneta Tomescu and Stelian Paris

European Journal of Natural Scinces and Medicine Articles, 2019, vol. 2

Abstract: Because the falsification of medicines is a global problem, requires increased and effective international coordination and cooperation to ensure the effectiveness of the strategies to combat counterfeiting, especially in relation to the sale of such products on the Internet. In the context of people’s health and life rank foremost among the values and interests protected by the TFEU, this article examines the evolution of the legislative process regulating the internal market for medicinal products in order to ensure a high level of protection of public health against falsified medicines and to present the legislative initiatives that have been taken at EU level taking account of new risk profiles, measures meant to ensure, at the same time, the functioning of the internal market of medicinal products. However, this article aims to address consumers’ right to have access to safe, effective, quality and innovative medicinal products as a right of the European patient. Ensuring the free movement of medicinal products on the EU market must not violate or restrict this fundamental right of thepatient.The threat that falsified medicines pose to public health is also recognized by the World Health Organization (WHO), which has established the International Medical Products Anti-Counterfeiting Taskforce ("IMPACT").IMPACT has developed the Principles and Elements for National Legislation against Counterfeit Medical Products, which were endorsed by the IMPACT General Meeting in Lisbon on 12 December 2007.

Keywords: patient rights; European legislation; the European Union; counterfeit medicinal products; public health; legislative initiatives; internal market; legal supply chain (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://brucol.be/index.php/ejmn/article/view/5009 (text/html)
https://brucol.be/files/articles/ejmn_v2_i1_19/Erimia.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eur:ejmnjr:2

DOI: 10.26417/770tyt30x

Access Statistics for this article

More articles in European Journal of Natural Scinces and Medicine Articles from Revistia Research and Publishing
Bibliographic data for series maintained by Revistia Research and Publishing ().